Key result
Impaired pulmonary function is linked to reduced exercise capacity and higher mortality in HFpEF.
Its licence doesn't allow us to show a copy here.
Why the study?
Does pulmonary function impairment (%VC and %FEV₁) associate with reduced exercise capacity, hemodynamic derangements, and worse clinical outcomes (all-cause death or worsening heart failure) in symptomatic patients with HFpEF?
Cohort (n=486)
Does pulmonary function impairment (%VC and %FEV₁) associate with reduced exercise capacity, hemodynamic derangements, and worse clinical outcomes (all-cause death or worsening heart failure) in symptomatic patients with HFpEF?
In symptomatic patients with HFpEF, impaired pulmonary function (specifically lower %VC and %FEV₁) is associated with reduced exercise capacity, exercise-induced biventricular hemodynamic abnormalities, and an increased risk of all-cause death or worsening heart failure.
May support spirometry for HFpEF risk stratification; hypothesis-generating and requires prospective validation before practice change.
Pulmonary function impairment is common in heart failure with preserved ejection fraction (HFpEF). However, its relationships with exercise capacity, cardiovascular reserve capacity, and prognosis in HFpEF remain uncertain. We retrospectively studied symptomatic patients undergoing exercise stress echocardiography with simultaneous expired gas analysis. Cross-sectional analyses were performed to compare pulmonary function in patients with HFpEF and symptomatic controls in the cohort with available data on percent predicted vital capacity (%VC) and forced expiratory volume in 1 s (%FEV₁). Outcome assessment was also performed in a subset of patients. Among 486 patients in the cross-sectional cohort, 178 had HFpEF and 308 were symptomatic controls. Patients with HFpEF had lower %VC and %FEV₁ than controls. After adjustment for age, sex, and body mass index, lower %VC and %FEV₁ were consistently associated with reduced exercise capacity, higher echocardiographic estimates of left ventricular filling pressure (E/e') and reduced right ventricular systolic function during exercise. Prognostic analyses were performed in the HFpEF cohort with follow-up data (N = 148). There were 37 primary composite events of all-cause death or worsening heart failure over a median follow-up of 935 days. Lower %VC was associated with a higher risk of the primary composite endpoint and remained associated in multivariable models. The %FEV₁ showed a weaker but concordant association. Lower %VC and %FEV₁ were associated with reduced exercise capacity and hemodynamic derangements in the overall cohort and with worse clinical outcomes in patients with HFpEF.
No takes yet. Share an insight, caveat, or question.
Kuno et al. (2026) conducted a cohort in Heart failure with preserved ejection fraction (HFpEF) (n=486). Pulmonary function impairment (lower %VC and %FEV1) vs. Symptomatic controls without HFpEF / higher %VC and %FEV1 was evaluated on Composite of all-cause death or worsening heart failure. Lower %VC and %FEV1 were associated with reduced exercise capacity and higher risk of all-cause death or worsening HF in HFpEF (37 events in 148 patients over 935 days).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: